Lung Mucus Hypersecretion and NQO1
Dependency of O3-Induced Lung Mucus Hypersecretion on NQO1
3 other identifiers
observational
60
1 country
1
Brief Summary
The research plan proposes translational studies in relevant animal models and human subjects in order to identify host (genetic) susceptibility factors that confer vulnerability to the prototypal air pollutant, ozone. The results will have significant impact upon, and aid in, understanding mechanisms regulating pro-oxidant lung injury, production and secretion of airway mucins, and clearance of respiratory mucus, and adverse health effects, that occur during and following exposure to airborne respiratory irritants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2008
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2008
CompletedFirst Submitted
Initial submission to the registry
August 6, 2008
CompletedFirst Posted
Study publicly available on registry
August 7, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2012
CompletedSeptember 29, 2014
September 1, 2014
3.2 years
August 6, 2008
September 25, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Airway Mucociliary Clearance
6-24 h post-exposure to filatered air or ozone.
Secondary Outcomes (1)
Bronchial Epithelial Cells obtained by bronchoalveolar lavage.
6-24 h post-exposure to filtered air or ozone.
Study Arms (2)
Control group
18-35 yr old healthy subjects with wild type genotype for NQO1.
Case group
18-35 yr old healthy subjects who are homozygotic for minor allele of NQO1 Pro187Ser polymorphism
Eligibility Criteria
Subjects will be healthy adults, non-smokers, recruited from the University campus and local community. Fifty% will be female. Recruitment of minority ethnic groups will be consistent with census population for central NC. Subjects will have a clinical history and lung function screening at protocol entry. Female subjects of childbearing age will have pregnancy testing. Equal numbers of NQO1 sufficient and deficient subjects, based upon genoytypic pre-screening and stratified by racial background will be studied. Subjects will also be genotyped for GSTM1 wild type or null genotype. As individuals with an increased BMI may respond strongly to O3 we will only recruit subjects with body habitus within normal range for gender, age, and racial group.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Duke University Medical Center
Durham, North Carolina, 27710, United States
Biospecimen
Bronchoalveolar lavage specimens.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CROSSOVER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NIH
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
August 6, 2008
First Posted
August 7, 2008
Study Start
August 1, 2008
Primary Completion
October 1, 2011
Study Completion
June 1, 2012
Last Updated
September 29, 2014
Record last verified: 2014-09